Cargando…
Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinoma
Ocular immune-related adverse events are a relatively rare complication of immune checkpoint inhibitors. Common ocular toxicities range from dry eyes to inflammatory uveitis and ocular myasthenia gravis. Here, we present the case of a 55-year-old woman with recurrent urothelial carcinoma of the uret...
Autores principales: | Nguyen, Charles B., Su, Christopher T., Morgan, Meredith, Alva, Ajjai S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582237/ https://www.ncbi.nlm.nih.gov/pubmed/36276085 http://dx.doi.org/10.3389/fonc.2022.1000023 |
Ejemplares similares
-
Urothelial Cancer With Occult Bone Marrow Metastases and Isolated Thrombocytopenia
por: Alva, Ajjai, et al.
Publicado: (2015) -
Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction
por: Maskin, Steven L, et al.
Publicado: (2018) -
A Novel Quantitative Index of Meibomian Gland Dysfunction, the Meibomian Gland Tortuosity
por: Lin, Xiaolei, et al.
Publicado: (2020) -
Uneven Meibomian Gland Dropout in Patients with Meibomian Gland Dysfunction and Demodex Infestation
por: Yu, Xinxin, et al.
Publicado: (2022) -
Meibomian Gland Dysfunction: Endocrine Aspects
por: Sahin, Ozlem G., et al.
Publicado: (2011)